2022 full-year guidance:
- Revenue of $1.79 billion to $1.8 billion
- GAAP operating loss of $8 million to $13 million
- Adjusted EBITDA of $420 million to $425 million
2023 expectations:
- Revenue of $2.28 billion to $2.33 billion
- GAAP operating income of $115 million to $140 million
- Adjusted EBITDA of $595 million to $630 million
“As we head into 2023, we are focused on executing our strategic plan, including advancing our technology investments and driving our best-in-class commercial engine to deliver value for our customers and team members,” CEO Lee Rivas said in the release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
